Pharmacokinetics, biodistribution, and biosafety of PEGylated gold nanoparticles in vivo - Kozics, Katarina (Biomedical Research Center SAS (Bratislava, Eslovàquia). Department of Nanobiology) ; Sramkova, Monika (Biomedical Research Center SAS (Bratislava, Eslovàquia). Department of Nanobiology) ; Kopecka, Kristina (Biomedical Research Center SAS (Bratislava, Eslovàquia). Department of Nanobiology) ; Begerova, Patricia (Biomedical Research Center SAS (Bratislava, Eslovàquia). Department of Nanobiology) ; Manova, Alena (Slovak University of Technology in Bratislava. Institute of Analytical Chemistry) ; Krivosikova, Zora (Slovak Medical University in Bratislava. Department of Clinical and Experimental Pharmacotherapy) ; Sevcikova, Zuzana (University of Veterinary Medicine and Pharmacy in Kosice. Department of Morphological Disciplines) ; Liskova, Aurelia (Slovak Medical University in Bratislava. Laboratory of Immunotoxicology) ; Rollerová, Eva (Slovak Medical University in Bratislava. Laboratory of Toxicology) ; Dubaj, Tibor (Slovak University of Technology in Bratislava. Institute of Physical Chemistry and Chemical Physics) ; Puntes, Víctor (Institut Català de Nanociència i Nanotecnologia) ; Wsolova, Ladislava (Slovak Medical University in Bratislava. Laboratory of Toxicology) ; Šimon, Peter (Slovak University of Technology in Bratislava. Institute of Physical Chemistry and Chemical Physics) ; Tulinska, Jana (Slovak Medical University in Bratislava. Laboratory of Immunotoxicology) ; Gabelova, Alena (Biomedical Research Center SAS. Department of Nanobiology)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>